SeqOne PGxPharmacogenomics, now in the SeqOne Platform.
Turn the sequencing data you already generate into drug-response insight. No new assay, no new sample.
Introducing our new PGx module, SomaHRD v2, and more than 80 features and improvements, all IVDR certified from day one, so labs can give more patients a clear answer, sooner.
Pick your area: what matters to you moves to the top of every section.
Turn the sequencing data you already generate into drug-response insight. No new assay, no new sample.
Clear, reproducible HRD calls, even on the low-coverage, low-tumor samples where answers are hardest to get.
Pharmacogenomics, without a new test. SeqOne PGx runs on the sequencing data your lab already generates, no separate assay, no new sample, no added turnaround time. It's now an official part of the platform, not a preview.
Homologous recombination deficiency, called reliably on the material an oncology lab actually has. A rebuilt algorithm, validated against the reference assay, and locked so the same sample always returns the same score.
Events you couldn't call before, files you can now bring in, and fusions handled end to end.
Nothing in this part is specific to .
A fusion is no longer something you only look at. Open it, classify it, read the evidence, and report it, in one workflow.
Large inversions now show up in your WES and panel data, including the inversion events a hereditary cancer panel depends on, such as the Boland inversion in MSH2 (Lynch syndrome).
GermVar Family now distinguishes “not covered” from “reference” on a per-family-member basis, removing a common source of ambiguity in family review.
Bring your own BAM or genome browser track files for read-level confirmation, for instance in the field's most challenging paralogous regions, and report with confidence on genes tied to conditions like spinal muscular atrophy, congenital adrenal hyperplasia and Lynch syndrome.
Every genome browser in the platform now runs on igv.js 3, and a quick IGV lookup sits on every variant row. Hover to see the reads at the variant, click to open the whole family.
SomaLBx no longer applies hard PASS filtering in the pipeline: every variant is retained, and you choose what to screen out in the viewer.
A redesigned ACMG workflow for germline, a new oncogenicity axis for somatic, and every call carried through to the signed report.
Nothing in this part is specific to .
We rebuilt ACMG from the engine up. The automatic classification follows the latest ClinGen guidance, reviewing it takes a few clicks, and the classification you validate is saved and reused across SeqOne, for SNVs as well as CNVs and SVs.
Oncogenicity is now a classification of its own. Every somatic SNV and indel gets an automatic call based on ClinGen/CGC/VICC guidelines, auditable criterion by criterion, and short variants, CNVs and fusions can all be classified in the same drawer. The class then follows each variant through to the report.
Review, classify and report CNVs without leaving the page, with variant comments that write themselves from your annotations and decisions, such as the ACMG criteria applied.
Variant details stay open next to the drawer, so you never lose context mid-call.
The Variant table now shows the most clinically relevant transcript first for every variant, so the right information is on screen without opening the dropdown.
Scored literature for germline variants, trials and cancer data for somatic ones: the evidence now comes to you on the variant page.
Nothing in this part is specific to .
Stop combing through the literature variant by variant. From the new Literature tab, LitFinder returns up to ten articles, each scored out of 100 with its reasoning alongside.
Autofill now drafts the interpretation comment for germline CNVs, for you to review and validate.
A Clinical Trials tab in the Evidences panel surfaces relevant trials for short variants and CNVs, without a separate search.
The AMP tier reads the same across all three somatic viewers, and the evidence behind a variant goes into its description in one click.
SomaCGP CNVs now carry the same clinical evidence as short variants, in the same place.
COSMIC frequency data now appears on the variant page, so you can judge a variant's somatic significance without leaving the analysis.
Statuses, comments and case details kept where everyone can see them, with panels, presets and report sections that follow your lab's practice.
Nothing in this part is specific to .
Raise a question on a variant, bring in a colleague, and close the loop once it’s settled, without leaving the analysis or switching tools.
The analysis list now shows what matters in one place, so you can spot the cases that need you and act on them.
Add your own columns to the analysis list to track the case details your lab cares about. Setting them up now takes one short form, opened right from the list.
Give your team the consistency of locked presets, or the flexibility of free filtering, whichever the project needs.
Set the right scope from the start, and adjust it without restarting your workflow.
Shape the report around your lab's practice, with a form that's quicker to move through.
We reworked the QC tab to make it clearer, and easier to read, understand and export. It now tells you what failed, on which sample and by how much, and the report prints and exports the way your lab needs it.
Faster file transfers, a cleaner export for your LIMS, and more of the platform available to your own systems through the public API.
Nothing in this part is specific to .
Uploads and downloads in the platform now go straight to and from storage, instead of through an intermediate file server, so large files move faster and more reliably, even with many users at once.
The JSON export now delivers one self-describing record per variant, so LIMS integrators no longer have to reverse-engineer cryptic keys and number-coded values.
Labs moving from another platform, or running their own automation, can import their pre-classified variants in bulk through the public API, without going through Customer Care.
More of what you do in the interface is now available to your LIMS and scripts, with 10 new public API endpoints.
All major clinical databases updated to their latest releases, with an up-to-date Disease Ontology to better link evidence to the patient's cancer.
Every release carries work that doesn't make a headline: steadier workflows, smoother details, and changes that come straight from your feedback.
All workset versions shipping with the Fall 2026 Release are IVD and fully validated.
| Workset | Legacy IVD version | New IVD version |
|---|---|---|
| Germline | ||
| CNV Capture | 2.6 | 2.6 |
| CNV Exome | 2.2 | 2.3 |
| GermlineVar | 2.6 | 2.7 |
| GermlineFamily | 2.6 | 2.7 |
| GermlineVar LR | 1.2 | 1.2 |
| GermVar | 3.12 | 3.15 |
| GermVar Family | 3.12 | 3.15 |
| GermVar Tertiary | 1.16 | 1.19 |
| GermVar Tertiary Family | 1.14 | 1.17 |
| Somatic | ||
| SomaCGP | 1.6 | 1.9 |
| SomaCNVcapture | 2.4 | 2.5 |
| SomaHemato | 0.6 | 0.8 |
| SomaHRD | 1.5 | 2.1 |
| SomaLBx | 0.7 | 0.10 |
| SomaMethyl | 0.3 | 0.3 |
| SomaMSI | 1.1 | 1.2 |
| SomaRNA | 3.3 | 3.5 |
| SomaVar | 2.9 | 2.11 |
| SomaVar LF | 2.1 | 2.1 |
| SomaVar Tertiary | 2.4 | 2.6 |
The SeqOne Platform is an in vitro diagnostic medical device, CE-IVD Class C certified under IVDR. The company is certified under ISO 13485 for medical device manufacturer, and under ISO 27001 and HDS for information security and health data hosting. All certificates are available at trust.seqone.com.